Pro Research: Wall Street eyes Alnylam’s RNAi therapeutics potential Investing.com Pro Research: Wall Street eyes Alnylam’s RNAi therapeutics potential. Science Wall Street 6 hours
US-China research has given Beijing’s military technology a boost, House GOP says MarketBeat 10 hours
Side-by-side images from the James Webb and Hubble space telescopes show why NASA spent 25 years and $10 billion on the Webb Business Insider 11 hours
Investors clinging to cash face these two risks as the Fed cuts interest rates, researchers say MarketWatch 13 hours
Earth is about to get a 2nd moon for 57 days only. Here’s what you need to know. Business Insider 14 hours
The RFK Jr.-Nuzzi relationship had reportedly become an open secret in some circles before the news broke Business Insider 14 hours
Morgan Stanley Boosts Jefferies Financial Group (NYSE:JEF) Price Target to $64.00 MarketBeat 15 hours
Does LiveRamp (RAMP) Have the Potential to Rally 73.68% as Wall Street Analysts Expect? Zacks 18 hours